CD36 deficiency results from genetic mutations leading to a loss of CD36. Clinical observations link this deficiency with hyperlipidemia, insulin resistance, and cardiomyopathy.
Variant Characterization
Three variants, P90S, E123K, and S127L, are frequently found together and are associated with variable phenotypes. These variants are located in a common structural region of CD36.
HEK293 Cell Studies
In a study utilizing HEK293 cells, the three variants demonstrated impaired binding and uptake of oxidized low-density lipoprotein (oxLDL). This impairment correlated with decreased expression levels and reduced half-lives of the receptors. Altered glycosylation processes were observed in the variants.
Experiments indicated that inhibiting proteasomal or lysosomal pathways did not restore the stability of the variants. The reduced receptor abundance was not due to a single degradation pathway. The variants exhibited diminished membrane accumulation without preferential localization to specific intracellular compartments.
These findings offer insight into the regulation of human CD36 expression, maturation, and trafficking. The study highlights the functional consequences of genetic variation related to CD36.